Literature DB >> 16205966

Obstructive hydrocephalus and intracranial hypertension caused by a giant macroprolactinoma. Prompt response to medical treatment.

Pietro Scarone1, Marco Losa, Pietro Mortini, Massimo Giovanelli.   

Abstract

Patients with large prolactin (PRL)-secreting pituitary adenoma often have symptoms due to varying degree of hypopituitarism and/or mass effect on visual structures, while presentation with hydrocephalus is extremely uncommon. Even more exceptional is the development of the syndrome of intracranial hypertension as a consequence of tumor obstruction of the cerebrospinal fluid circulation. In this report, we describe a 26-year-old man who was referred to the emergency department of our hospital because of headache, nausea, and vomiting. Clinical and radiological assessment led to the diagnosis of obstructive hydrocephalus caused by a giant macroprolactinoma. The patient received a temporary external ventricular drainage to relieve the symptoms of intracranial hypertension. The same day, after we received the result of the basal PRL level, medical treatment with cabergoline was initiated. A prompt response to the drug ensued with resolution of the obstructive hydrocephalus, which allowed removal of the external ventricular drainage. Initial shrinkage of the mass was already noted on a magnetic resonance imaging performed 12 days thereafter. Subsequent medical treatment led to progressive and marked shrinkage of the tumor. Eighteen months after presentation the patient was well while on cabergoline treatment and showed no symptom attributable to compression of the surrounding nervous structures. Our report confirms that, even in cases of giant sellar mass with neurological symptoms, a rapid hormonal evaluation is mandatory. If a macroprolactinoma is diagnosed, treatment with dopamine agonists can lead to prompt clinical amelioration and shrinkage of the tumor, with eventual resolution of neurological symptoms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16205966     DOI: 10.1007/s11060-005-2319-0

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  13 in total

1.  Fluctuating confusional state due to massive macro-prolactinoma resulting in obstructive hydrocephalus.

Authors:  P K Sarkar; R Manapuzha; S Ahmad; A E Ritch
Journal:  Age Ageing       Date:  2001-09       Impact factor: 10.668

Review 2.  Clinical practice. Prolactinoma.

Authors:  Janet A Schlechte
Journal:  N Engl J Med       Date:  2003-11-20       Impact factor: 91.245

3.  Obstructive hydrocephalus as complication of a giant nonfunctioning pituitary adenoma: therapeutical approach.

Authors:  J Verhelst; J Berwaerts; R Abs; G Dua; D Van Den Weyngaert; C Mahler
Journal:  Acta Clin Belg       Date:  1998-02       Impact factor: 1.264

4.  Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients.

Authors:  A Colao; A Di Sarno; M L Landi; F Scavuzzo; P Cappabianca; R Pivonello; R Volpe; F Di Salle; S Cirillo; L Annunziato; G Lombardi
Journal:  J Clin Endocrinol Metab       Date:  2000-06       Impact factor: 5.958

Review 5.  Medical treatment of prolactinomas.

Authors:  M E Molitch
Journal:  Endocrinol Metab Clin North Am       Date:  1999-03       Impact factor: 4.741

Review 6.  Clinical review 110: Diagnosis and treatment of pituitary tumors.

Authors:  P U Freda; S L Wardlaw
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

7.  Dopamine agonists and pituitary tumor shrinkage.

Authors:  J S Bevan; J Webster; C W Burke; M F Scanlon
Journal:  Endocr Rev       Date:  1992-05       Impact factor: 19.871

8.  Hydrocephalus complicating pituitary adenoma.

Authors:  H A Shenkin; J N Crowley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-12       Impact factor: 10.154

9.  Prolactinoma manifesting with symptomatic hydrocephalus.

Authors:  O M Zikel; J L Atkinson; D L Hurley
Journal:  Mayo Clin Proc       Date:  1999-05       Impact factor: 7.616

10.  Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study.

Authors:  M E Molitch; R L Elton; R E Blackwell; B Caldwell; R J Chang; R Jaffe; G Joplin; R J Robbins; J Tyson; M O Thorner
Journal:  J Clin Endocrinol Metab       Date:  1985-04       Impact factor: 5.958

View more
  5 in total

1.  Unusual association of a pituitary adenoma and a neurological emergency: case report and diagnostic steps.

Authors:  Marina Baldini; Lorena Airaghi; Alessandra Orsatti; Alberto Tedeschi; Tiziana Ceraldi; Clara Sina; Maria Domenica Cappellini
Journal:  Intern Emerg Med       Date:  2008-02-22       Impact factor: 3.397

Review 2.  How to investigate and treat: headache and hyperprolactinemia.

Authors:  Gennaro Bussone; Susanna Usai; Franca Moschiano
Journal:  Curr Pain Headache Rep       Date:  2012-08

Review 3.  Giant pituitary adenoma: histological types, clinical features and therapeutic approaches.

Authors:  Pedro Iglesias; Víctor Rodríguez Berrocal; Juan José Díez
Journal:  Endocrine       Date:  2018-06-16       Impact factor: 3.633

4.  Neurological, psychiatric, ophthalmological, and endocrine complications in giant male prolactinomas: An observational study in Algerian population.

Authors:  Farida Chentli; Said Azzoug; Katia Daffeur; Lina Akkache; Hadjer Zellagui; Meriem Haddad; Nadia Kalafate
Journal:  Indian J Endocrinol Metab       Date:  2015 May-Jun

5.  Unilateral hydrocephalus from a gangliocytoma-somatotrophinoma: first reported case.

Authors:  Simon Ryder; Jed Robusto; Thomas Robertson; Hamish Alexander; Emma L Duncan
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2021-07-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.